Drug Tariffs Are a Sideshow. Trump's Next Move Could Hit Pharma Harder.
WSJยท2025-09-27 09:30
Core Viewpoint - Investors are increasingly concerned about the lack of clarity regarding drug pricing, which is creating uncertainty in the market [1] Group 1 - The ambiguity in drug pricing is causing unease among investors [1] - This uncertainty may impact investment decisions and market stability [1]